24 Nations, One Standard — India’s Pharmacopoeia Goes Global

Date:

Share post:

The Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with Lao PDR’s Food and Drug Department and Ministry of Health, marking a significant step in India’s growing influence over global medicine quality standards.

The agreement was formalized at the 10th India–Lao PDR Joint Commission Meeting, co-chaired by External Affairs Minister Dr. S. Jaishankar, underscoring the strategic depth of bilateral healthcare ties.

With Lao PDR onboard, the Indian Pharmacopoeia now holds formal recognition across 24 countries — a testament to the world’s growing confidence in India’s regulatory and scientific frameworks.

This milestone reinforces India’s position as a trusted global authority in ensuring medicines are safe, effective, and quality-assured.

India is not just manufacturing medicines for the world — it is now setting the standard for them.

Written by: Sharon Bose & Arundhuti Chatterjee

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Cognizant Expands Strategic Partnership with Novartis to Transform Global IT Operations using Agentic AI

Cognizant has announced a new five-year, AI-enabled integrated IT operations agreement with Novartis, expanding a strategic relationship that...

Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown

The Central Drugs Standard Control Organisation (CDSCO) has withdrawn registration certificates from seven Ethics Committees nationwide after risk-based...

From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story

Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a...

Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP

Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar...